P. A. Clarke et al. / Tetrahedron Letters 47 (2006) 1453–1455
1455
O
O
O
t-
BuO C
2
i, ii
OTBS
O
4
13
Scheme 2. Reagents and conditions: (i) HF, MeCN; (ii) TFA, CH2Cl2,
71% (over two steps).
tert-butyl ester and in situ lactonisation with TFA. An
X-ray crystal structure of 13 revealed that the ketone
carbonyl and H(2) were appropriately aligned for enoli-
sation to occur (Fig. 4), if conditions could be found.
We were confident that enolisation would not occur
between C(9) and C(1) as that would necessitate the
formation of an anti-Bredt bridgehead double bond.
Figure 5. X-ray structure of compound 14.
carbon–carbon double bond. This extends the scope of
transannulation reactions in the synthesis of complex
and biologically active natural products. Work is on
going to apply this strategy to the synthesis of pinguise-
nol and acutifolone A, and these studies will be reported
in due course.
Acknowledgements
We thank the EPSRC and Pfizer for studentship funding
(R.J.G.B.) and AstraZeneca for an unrestricted research
award (P.A.C.).
References and notes
1. (a) Asakawa, Y. In Progress in the Chemistry of Organic
Natural Products; Herz, W., Kirby, G. W., Moore, R. E.,
Steglich, W., Tamm, Ch., Eds.; Springer: Wien, New York,
1995; Vol. 65, p 1; (b) Asakawa, Y.; Toyota, M.; Aratani,
T. Tetrahedron Lett. 1976, 40, 3619; (c) Hashimoto, T.;
Irita, H.; Tanaka, M.; Takaoka, S.; Asakawa, Y. Tetra-
hedron Lett. 1998, 39, 2977.
Figure 4. X-ray structure of lactone 13.
We rationalised that a Brønsted acid capable of promot-
ing enolisation as well as protonation of the double
bond on the other side of the ring would stand the best
chance of success. To this end we treated 13 with 15 eq.
of HBF4 in Et2O/AcOH, and we were delighted to
witness the clean formation of a new product, which
was identified by comprehensive NMR spectroscopy
and X-ray crystallography as the desired bicyclo-
[4.3.0]nonane ring system 14 (Scheme 3, Fig. 5). The
lactone was opened with NaOMe in MeOH to yield
the bicyclo[4.3.0]nonane core of the pinguisane-type
sesquiterpenoids complete with the vicinal quaternary
centres, as a single enantiomer.
2. Belkin, M.; Fitzgerald, D.; Felix, M. D. J. Natl. Cancer
Inst. 1952–53, 13, 741.
3. (a) McCleary, J. A.; Walkington, D. A. Rev. Bryol.
Lichenol. 1966, 34, 309; (b) Wolters, B. Planta 1964, 62, 88.
4. Wada, K.; Munakata, K. Agr. Biol. Chem. 1971, 35, 115.
5. (a) Gerling, K.-G.; Wolf, H. Tetrahedron Lett. 1985, 26,
1293; (b) Tori, M.; Hasebe, T.; Asakawa, Y. Chem. Lett.
1988, 2059; (c) Schinzer, D.; Ringe, K. Tetrahedron 1996,
52, 7475; (d) Srikrishna, A.; Vijaykumar, D. J. Chem. Soc.,
Perkin Trans. 1 1997, 3295; (e) Sha, C. K.; Liao, H.-W.;
Cheng, P.-C.; Yen, S.-C. J. Org. Chem. 2003, 68, 8704; (f)
Srikrishna, A.; Vijaykumar, D. Tetrahedron Lett. 1998, 39,
4901.
6. (a) Shiina, J.; Nishiyama, S. Tetrahedron 2003, 59, 6039;
(b) Shiina, J.; Nishiyama, S. Tetrahedron Lett. 2004, 45,
9033; (c) Shiina, J.; Nishiyama, S. Tetrahedron Lett. 2005,
46, 7683.
7. Harada, K.; Tonoi, Y.; Hiroaki, K.; Fukuyama, Y.
Tetrahedron Lett. 2002, 43, 3829.
8. Mateos, F. A.; Barrueco, F. O.; Gonzaalez, R. R.
Tetrahedron Lett. 1990, 31, 4343.
9. Clarke, P. A.; Grist, M.; Ebden, M.; Wilson, C. Chem.
Commun. 2003, 1560.
O
O
O
O
O
OH
O
i
ii
MeO C
2
O
13
14
15
Scheme 3. Reagents and conditions: (i) 54% HBF4 in Et2O, AcOH,
66%; (ii) NaOMe, MeOH, 70%.
10. Clarke, P. A.; Grist, M.; Ebden, M.; Wilson, C.; Blake, A.
J. Tetrahedron 2005, 61, 353.
11. Clarke, P. A.; Grist, M.; Ebden, M. Tetrahedron Lett.
2004, 45, 927.
12. Crimmins, M. T.; King, B. W.; Tabet, E. A.; Chaudhary,
K. J. Org. Chem. 2001, 66, 894.
In conclusion, we have developed a conceptually novel
asymmetric approach to the construction of the bicy-
clo[4.3.0]nonane ring systems of the pinguisane-type ses-
quiterpenoids, by use of a Brønsted acid promoted
transannular cyclisation of an enol onto an unactivated